Zijun Kuang

No ORCID on file · 14 papers in corpus · active 2024-2026

Study types

  • article 10
  • other 4

Condition tags

  • endometriosis 13
  • adenomyosis 1
article 2026
Additional file 1 of Mechanisms of Luoshi Neiyi prescription (LSNYP) in endometriosis: a network pharmacology and experimental study
·doi:10.6084/m9.figshare.31330008.v1

Supplementary Material 1: 14 herbs of LSNYP.

article 2026
Additional file 1 of Mechanisms of Luoshi Neiyi prescription (LSNYP) in endometriosis: a network pharmacology and experimental study
·doi:10.6084/m9.figshare.31330008

Supplementary Material 1: 14 herbs of LSNYP.

article 2026
Additional file 2 of Mechanisms of Luoshi Neiyi prescription (LSNYP) in endometriosis: a network pharmacology and experimental study
·doi:10.6084/m9.figshare.31330011

Supplementary Material 2: 114 Potential active components.

article 2026
Additional file 2 of Mechanisms of Luoshi Neiyi prescription (LSNYP) in endometriosis: a network pharmacology and experimental study
·doi:10.6084/m9.figshare.31330011.v1

Supplementary Material 2: 114 Potential active components.

article 2026
Additional file 3 of Mechanisms of Luoshi Neiyi prescription (LSNYP) in endometriosis: a network pharmacology and experimental study
·doi:10.6084/m9.figshare.31330014

Supplementary Material 3: 217 potential therapeutic targets.

article 2026
Additional file 3 of Mechanisms of Luoshi Neiyi prescription (LSNYP) in endometriosis: a network pharmacology and experimental study
·doi:10.6084/m9.figshare.31330014.v1

Supplementary Material 3: 217 potential therapeutic targets.

article 2026
Additional file 4 of Mechanisms of Luoshi Neiyi prescription (LSNYP) in endometriosis: a network pharmacology and experimental study
·doi:10.6084/m9.figshare.31330017.v1

Supplementary Material 4: Main quality control components were identified by UHPLC-Q/TOF-MS.

article 2026
Additional file 4 of Mechanisms of Luoshi Neiyi prescription (LSNYP) in endometriosis: a network pharmacology and experimental study
·doi:10.6084/m9.figshare.31330017

Supplementary Material 4: Main quality control components were identified by UHPLC-Q/TOF-MS.

other 2026
Mechanisms of Luoshi Neiyi prescription (LSNYP) in endometriosis: a network pharmacology and experimental study
·doi:10.6084/m9.figshare.c.8307684

Abstract Background Luoshi Neiyi prescription (LSNYP) is a traditional Chinese medicine that has a clinical effect on endometriosis (EMs). This study combined network pharmacology with experimental validation to explore its potential molecu…

other 2026
Mechanisms of Luoshi Neiyi prescription (LSNYP) in endometriosis: a network pharmacology and experimental study
·doi:10.6084/m9.figshare.c.8307684.v1

Abstract Background Luoshi Neiyi prescription (LSNYP) is a traditional Chinese medicine that has a clinical effect on endometriosis (EMs). This study combined network pharmacology with experimental validation to explore its potential molecu…

other 2026
Mechanisms of Luoshi Neiyi prescription (LSNYP) in endometriosis: a network pharmacology and experimental study
Hereditas ·doi:10.1186/s41065-026-00637-2

BACKGROUND: Luoshi Neiyi prescription (LSNYP) is a traditional Chinese medicine that has a clinical effect on endometriosis (EMs). This study combined network pharmacology with experimental validation to explore its potential molecular mech…

other 2025
Shaoyao gancao decoction induces autophagy by modulating miR-21 and inhibiting the AKT/mTOR signaling pathway in adenomyosis-derived ectopic endometrial stromal cells
Frontiers in pharmacology ·doi:10.3389/fphar.2025.1665911

ETHNOPHARMACOLOGICAL RELEVANCE: Shaoyao Gancao Decoction (SGD) is a renowned traditional Chinese medicinal formulation widely utilized in Asia. It is particularly effective in treating spastic, painful, and inflammatory conditions, especial…

article 2024
Luoshi Neiyi Prescription inhibits estradiol synthesis and inflammation in endometriosis through the HIF1A/EZH2/SF-1 pathway
Journal of ethnopharmacology ·doi:10.1016/j.jep.2024.118659

ETHNOPHARMACOLOGICAL RELEVANCE: Endometriosis (EMS) is a common gynecological disease that causes dysmenorrhea, chronic pelvic pain and infertility. Luoshi Neiyi Prescription (LSNYP), a traditional Chinese medicine (TCM) formula, is used to…

article 2024
[Mechanism of Luoshi Neiyi Formula in treatment of SF-1 on endometriosis by improving hypoxia]
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica ·doi:10.19540/j.cnki.cjcmm.20240531.401

This study investigated the effect of Luoshi Neiyi Formula(LSNYF) on hypoxia-inducible factor-1α(HIF-1α) and steroidogenic factor 1(SF-1) in endometriosis(EMs), aiming to explore the mechanism of Luoshi Neiyi Formula in treating EMs. Immuno…